Natalie Cotterell, Development Editor – Biomaterials Science Blog

Author Archive

Congratulations to the winners of the Bioceramics34 Young Scientist awards

19 Nov 2024

Biomaterials Science, Materials Horizons and Journal of Materials Chemistry B were pleased to support the recent Bioceramics34 conference which was held from 18 – 21 October 2024 in Shanghai, China. We were pleased to sponsor 7 Young Scientist Awards for the best presentations. Please join us in congratulating our winners and find out about some of them below!

Siyu Chen received her Ph.D. degree under the supervision of Prof. Xingdong Zhang in National Engineering Research Center for Biomaterials (NEBM), Sichuan University. She is now currently working as a postdoctoral researcher in West China Hospital. Her research focuses on biomaterials and implantable medical devices for musculoskeletal system, including calcium phosphate based-bioceramics, functionalized implants for diseased bone repair (i.e., osteoporosis, osteosarcoma), and cellular interaction between host and implant.

Siyu received an award sponsored by Biomaterials Science for her talk entitled ‘Biomimetic conch-shell structural (Mn, Co) co-doped piezoelectric scaffolds for anti-tumor therapy and bone regeneration’

Hang Ping received his PhD degree in materials processing engineering (2017) from the Wuhan University of Technology. He is currently a professor in Wuhan University of Technology. His research interests mainly focus on bioprocessing-inspired synthesis and fabrication. He has published more than 50 peer-reviewed papers as coauthors, authorized 6 invention patents in China, and hosted 3 projects from national natural science foundation of China.

Hang received an award sponsored by Materials Horizons for his talk entitled ‘Bioprocessing-inspired intrafibrillar collagen mineralization with megapascal contractile prestresses’

Jan Grzelak was born in 1993 in Warsaw, Poland. In 2012 he enrolled at the University of Warsaw, where he obtained a bachelor´s degree (B.Sc.) in Nanostructure Engineering and a master´s degree (M.Sc.), also in Nanostructure Engineering. In 2017, he was granted a “la Caixa” INPhINIT Fellowship to pursue a PhD degree in Materials Science at Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), under the supervision of Prof. Anna Roig Serra and Dr. Martí Gich Garcia, in the Nanoparticles and Nanocomposites Group. In October 2021, he obtained his PhD with Cum Laude qualification for his doctoral thesis entitled “Magnetic and fluorescent mesoporous silica nanorods towards liver theranostic uses”. Later, due to his interest in the biomedical applications of nanomaterials, he pursued an additional master’s degree in Biomedicine at the University of Barcelona. In January 2023, he started working as a postdoctoral researcher in the ERC project “Bio-inspired AntiMicrobial Bone Bioceramics: Deciphering contact-based biocidal mechanisms” (BAMBBI) in the research line of Biomaterials for Bone Regeneration led by Prof. Maria Pau Ginebra at the Polytechnic University of Catalonia (UPC), where he works on the development of calcium phosphate surfaces with tailored nanotopographies.

Jan was awarded a prize sponsored by Biomaterials Science for his talk entitled ‘Tailoring high-aspect-ratio antimicrobial calcium phosphate nanotopographies: Effect of processing parameters’

Comments Off on Congratulations to the winners of the Bioceramics34 Young Scientist awards

Open Call for Papers: Novel Biomedical Polymer Materials

21 Jul 2023

Open Call for Papers: Novel Biomedical Polymer Materials

Guest Edited by Professor Huayu Tian and Professor Xuesi Chen

We are delighted to announce a special themed collection on Novel Biomedical Polymer Materials to be published across Biomaterials Science and Journal of Materials Chemistry B. This collection is Guest Edited by:

Professor Huayu Tian (Xiamen University)

Professor Xuesi Chen (Changchun Institute of Applied Chemistry, University of the Chinese Academy of Sciences)

Submissions Deadline: 1 November 2023

Biomedical polymer materials, as materials for diagnosis, treatment and organ regeneration, have the mission of prolonging patients’ lives and improving their quality of life. Their research occupies a very important position in the fields of biotechnology, life sciences and medicine, and different fields of biomedicine have different requirements for biomedical materials. Thus, in order to promote the development of the medical field, the synthesis of new biomaterials is of great significance.

To this end, this themed collection in Journal of Materials Chemistry B and Biomaterials Science aims at providing a platform for recent developments in this rapidly evolving field and we encourage you to submit your latest research to feature in the collection.

Submissions to the journal should fit within the scope of Journal of Materials Chemistry B or Biomaterials Science – Please see the journal’s website for more information on the journal’s scope, standards, article types and author guidelines. You may submit to whichever journal you feel is most relevant to your current research. Please note that your article may be offered a transfer to the alternate journal if deemed more appropriate by the handling Editor. Articles that primarily focus on providing insight into the underlying science and performance of biomaterials within a biological environment are more suited to Biomaterials Science. whereas articles that primarily focus on demonstrating novel materials chemistry and bring a molecular picture on a given material’s suitability as a biomaterial are more suited to Journal of Materials Chemistry B.

For this collection, we strongly encourage full primary research in the way of Full Papers or Communications.

All manuscripts must be in scope for the journal and will undergo the normal initial assessment and peer review processes in line with the journal’s high standards, managed by the journal editors. Accepted manuscripts will be added to the online collection as soon as they are published and they will be featured in a regular issue of the relevant journal.

If you would like to contribute to this themed collection, please submit your article directly through the Biomaterials Science submission service or the Journal of Materials Chemistry B submission service. Please mention that your submission is a contribution to the Novel Biomedical Polymer Materials collection in the “Themed issues” section of the submission form and add a “Note to the Editor” that this is from the Open Call. The Editorial Office reserves the right to check suitability of submissions in relation to the scope of both the journal and the collection, and as such inclusion of accepted articles in the final themed collection is not guaranteed. All submissions will be subject to initial assessment and sent for peer review, if appropriate. We cannot guarantee peer review or acceptance of your submission in the journal.

If you have any questions about the collection or the submissions process, please do contact the Editorial Office at biomaterialsscience-rsc@rsc.org and they will be able to assist.

We look forward to receiving your latest work and considering it for this collection!

Comments Off on Open Call for Papers: Novel Biomedical Polymer Materials

Biomaterials Science- Lunar New Year 2023

01 Feb 2023

Biomaterials Science Lunar New Year collection 2023

To celebrate the Lunar New Year, we wanted to share with you some of the most popular articles published in Biomaterials Science in 2022 by corresponding authors based in countries celebrating the Lunar New Year.

Read the collection here

All articles in the collection are FREE to read until March, 2 2023

Check out a selection of the articles in the collection below:

Review

Manufacturing functional hydrogels for inducing angiogenic–osteogenic coupled progressions in hard tissue repairs: prospects and challenges

Anuj Kumar, Ankur Sood, Ritu Singhmar, Yogendra Kumar Mishra, Vijay Kumar Thakur and Sung Soo Han

Biomater. Sci., 2022, 10, 5472-5497, DOI: 10.1039/D2BM00894G

Papers

Pulmonary delivery of curcumin-loaded glycyrrhizic acid nanoparticles for anti-inflammatory therapy

Chunxian Piao, Chuanyu Zhuang, Minji Kang, Jihun Oha and Minhyung Lee

Biomater. Sci., 2022, 10, 6698-6706, DOI: 10.1039/D2BM00756H

N-Cadherin adhesive ligation regulates mechanosensitive neural stem cell lineage commitment in 3D matrices

Jieung Baek, Sanjay Kumar, David V. Schafferabd and Sung Gap Im

Biomater. Sci., 2022, 10, 6768-6777, DOI: 10.1039/D2BM01349E

Cationic polymer synergizing with a disulfide-containing enhancer achieved efficient nucleic acid and protein delivery

Yuanji Feng, Zhaopei Guo, Jie Chen, Sijia Zhang, Jiayan Wu, Huayu Tian and Xuesi Chen

Biomater. Sci., 2022, 10, 6230-6243, DOI: 10.1039/D2BM01211A

Rational design of a small organic photosensitizer for NIR-I imaging-guided synergistic photodynamic and photothermal therapy

Shibo Lv, Yuhan Liu, Yanliang Zhao, Xiaoxue Fan, Fangyuan Lv, Erting Feng, Dapeng Liu and Fengling Song

Biomater. Sci., 2022, 10, 4785-4795, DOI: 10.1039/D2BM00661H

Why not also read the Lunar New Year collection for our companion journal, Journal of Materials Chemistry B

Congratulations to all featured authors! We hope you enjoy reading some of these popular articles.

We wish you a happy and prosperous Year of the Rabbit.

Comments Off on Biomaterials Science- Lunar New Year 2023

Biomaterials Science Overview of 2022

20 Jan 2023

Now that 2022 has come to a close, join us as we look back at some of our highlights from last year and as we look forward to some of our upcoming activities in 2023!

Biomaterials Science 10^th Anniversary

October 2022 marked the 10^th Anniversary of Biomaterials Science. Our Editor-in-Chief, Jianjun Cheng and Executive Editor, Maria Southall wrote an Editorial reflecting on the progress of the journal over the past 10 years and look towards the future of Biomaterials Science.

We celebrated the anniversary with a number of activities such as:

· Biomaterials Science 10^th Anniversary collection featuring high quality research and review articles from some of the top authors in biomaterials

· Post-publication web collections from four of our key regions; Europe, China, North America and Asia-Pacific, featuring some of the most cited, most downloaded and most shared articles during the first 10 years of the journal

· ‘Reviewer spotlight’ recognising some of our most loyal outstanding reviewers who have supported the journal in the past few years

Keep an eye on our Twitter for the latest celebratory activities and check out the latest research published in the ongoing anniversary collection.

Biomaterials Science Top Picks of 2022

We have selected some of the most cited, most downloaded and most shared articles published in Biomaterials Science from last year for our Most Popular 2022 collection

All articles in this collection are FREE to read until 28 February 2023.

Congratulations to all featured authors!

Editorial Board

We welcomed Prof. Nasim Annabi (University of California, Los Angeles) to the Editorial Board of Biomaterials Science as an Associate Editor in February 2022. Prof. Annabi was the recipient of the Biomaterials Science Lectureship 2021 in recognition of her contributions to the biomaterials field. Her research involves the design and engineering of advanced biomaterials for applications in regenerative medicine.

Biomaterials Science Lectureship

The Biomaterials Science Lectureship 2022 was awarded to Dr Yizhou Dong (Ohio State University). This annual award was established in 2009 to honour an early-stage career scientist who has made a significant contribution to the biomaterials science field. Dr. Dong’s research focuses on the design and development of biotechnology platforms for the treatment of genetic disorders, infectious diseases, and cancers. To learn more about Yizhou Dong and his research, read our Lectureship winner blog post. You can check out articles from Yizhou and from our previous winners in the Lectureship winners collection.

The nominations for the 2023 Lectureship award are now closed. We have received a number of excellent nominations and we would like to thank everyone for their support. We look forward to announcing the winner later this year.

Biomaterials Science Emerging Investigators

Biomaterials Science is proud to spotlight our ongoing Emerging Investigators Series. Our Emerging Investigators are at the early stages of their independent careers and invited for this collection in recognition of their potential to influence future directions in the field. Congratulations to all the featured researchers on their important work so far!

Read the collection

Meet the Scientists

Themed collections

Read this ongoing themed collection in Biomaterials Science on ‘CRISPR biomaterials’, Guest Edited by Yuan Ping (Zheijiang University), Qiaobing Xu (Tufts University) and Ming Wang (Chinese Academy of Sciences).

Keep an eye out for the exciting work being added to the collection

Browse all past collections on our platform, and see our upcoming collections on our calls for submissions page. We will be announcing more collections during the year, so keep a look out!

Open calls

The deadline is soon approaching for this open call to submit your work to a themed collection on ‘Microneedles’ joint with our companion journal, Journal of Materials Chemistry B. Guest Edited by Ester Caffarel-Salvador (Scientific Consultant, USA), Ryan Donnelly (Queen’s University Belfast, UK), Harvinder Gill (Texas Tech University, USA) and Hyungil Jung (Yonsei University, Korea), this themed collection aims to bring together recent advancements in the field of microneedles, from materials design to application and all that is in between.

Read the collection so far

HOT articles

Remember to check out the Biomaterials Science HOT articles collection featuring hot articles highlighted by the Editors and referees. All articles in the collection are FREE to read until 28 February 2023.

Open Access

The Royal Society of Chemistry has announced that all 31 fully-owned hybrid journals, including Biomaterials Science, have been approved as “Transformative Journals” with cOAlition S, an international consortium of research funding and performing organisations. Find out more about our strive towards 100% Open Access here.

#RSCPoster: Save the date

#RSCPoster is a global Twitter Poster Conference, held entirely online over the course of 24 hours. The event brings together the global chemistry community to network with colleagues across the world and at every career stage, share their research and engage in scientific debate.

The 2023 #RSCPoster Twitter Conference will be held from 12:00 (UTC) 28 February 2023 to 12:00 (UTC) 1 March 2023.

How you can help…

We would like to take this opportunity to thank all of you in addition to our authors, reviewers and readers for their support throughout 2022. Here are some of the ways in which you can continue to make a positive contribution to Biomaterials Science:

Submit to one of our open themed collections and encourage your colleagues to submit.
If you are organising a conference or virtual event, please do let us know if you would like to arrange mutual promotion between the conference and Biomaterials Science. We can offer poster prizes, social media and blog promotion, and adverts in the journal and on the journal web page.
Read our recent articles and follow the latest news on the Biomaterials Science blog and on our Facebook and Twitter
Send your best research to Biomaterials Science.
Sign up to be a reviewer for Biomaterials Science.

Thank you for your continued interest in and support of Biomaterials Science. We look forward to seeing what 2023 brings!

Comments Off on Biomaterials Science Overview of 2022

Biomaterials Science Emerging investigator- Christopher Rodell

09 Dec 2022

Dr. Chris Rodell is an Assistant Professor in the School of Biomedical Engineering, Health and Science Systems at Drexel University. He conducted his doctoral research at the University of Pennsylvania, working on the development and in vivo application of injectable supramolecular hydrogels. Following completion of his PhD, Chris was a postdoctoral scholar with the Center for Systems Biology at Massachusetts General Hospital and Harvard Medical School, exploring drug delivery platforms for innate immune activation and their applications toward cancer immunotherapy. To date, Chris has authored more than 40 peer-reviewed publications, five patent applications, and numerous editorials. He is the recipient of a number of awards, including an American Heart Association Predoctoral Fellowship, a Materials Research Society Gold Award, the Solomon R. Pollack Award for excellence in graduate biomedical engineering (University of Pennsylvania), an Individual Biomedical Research Award (The Hartwell Foundation), and an R35 MIRA (NIGMS). His ongoing work leverages nanomaterials and injectable hydrogels as platforms for minimally-invasive therapeutic delivery. Examples include the local or systemic delivery of immunomodulatory drugs to re-orient the immune microenvironment for tissue healing and cancer treatment.

Read Chris’s Emerging Investigator article, ‘Sustained release of drug-loaded nanoparticles from injectable hydrogels enables long-term control of macrophage phenotype’, DOI: 10.1039/D2BM01113A

Check out our interview below:

1. How do you feel about Biomaterials Science as a place to publish research on this topic?

Biomaterials Science continues to be at the top of my reading list and is an outstanding outlet for communicating work related to material structure, composition, and biological function. Moreover, the journal has welcomed new directions in immune modulation and engineering that are critical areas of research growth as biomaterials continue to evolve as platforms for the understanding and therapeutic manipulation of either individual cell types or immune cell networks. Given the journal’s standing interest in biological applications and translation towards clinical use, it was an obvious choice for publishing our current work that focuses on developing polymer-nanoparticle hydrogels for local macrophage-targeted drug delivery.

2. What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?

The most exciting parts of this work are two-fold. First, we were interested in identifying drugs that could alter macrophage behavior – inhibiting inflammation while encouraging pro-healing behaviors. This was particularly challenging because it required the development of new drug screening methods as well as follow-up analysis in immune cells from both mice and humans to ensure drug activity was genuine. Finding a drug that meets these criteria is exciting for the immune modulation field, and we hope it will have broad applications in wound healing and regenerative medicine. The delivery of such immunosuppressive drugs, however, is often a problem clinically. This is because delivery throughout the body places patients at a greater risk of infection. The hydrogels developed overcome this by locally targeting drug delivery to specific cell types, potentially avoiding systemic immune suppression. I expect these materials to become a platform for delivering a library of suitable drugs, concentrating effects at the injection site while limiting off-target effects throughout the body that have continually derailed clinical trials.

3. In your opinion, what are the most important questions to be asked/answered in this field of research?

Some of the most critical and under-explored topics in immune modulation are related to how immune systems change in response to perturbations, including both injury and therapeutic delivery. Too often, cell types or single tissues are considered in isolation. In the context of macrophage-targeted therapeutics like the ones discussed here, it remains an open question as to which cells are best to manipulate. We can surely change the behavior of macrophages locally through drug delivery, but is this the most impactful approach? Considering the systems physiology, these cells generally have a short lifespan and are continually replaced by precursors from the bone marrow. Emerging evidence suggests that profound changes in these precursor cells drive long-term response to injury and link inflammatory co-morbidities (e.g., gum and heart disease, stroke and heart attack). Addressing these types of questions requires a broader systems biology thinking and is difficult to directly address experimentally. These are the types of problems we are beginning to address in my research group, which would not be possible without unique biomaterials platforms.

4. Can you share one piece of career-related advice or wisdom with other early career scientists?

Be happy. Just like Marie Kondo, find what sparks joy and hold onto it. It might be the location, environment, people, type of research, or any combination of these. I believe everyone is most productive in their life and work when they are happy. And frankly, you deserve it. Whether it’s a degree program or a long-term career, it’s a long-haul and you should be excited by what you do and where you are.

Find out more about Chris’s Tissue Instructive Materials lab on his website

Follow Chris and his research group on these social media:

Twitter: @ChrisRodell2 @DrexelBiomed

Chris’s Facebook and Department Facebook

Department Instagram

Chris’s Linkedin and Department Linkedin

Comments Off on Biomaterials Science Emerging investigator- Christopher Rodell

Open Call for Microneedles themed collection: Meet the Guest Editors

23 Nov 2022

Biomaterials Science and companion journal Journal of Materials Chemistry B are pleased to announce an open call for submissions to a cross-journal themed collection on ‘Microneedles’.

This cross-journal themed collection on ‘Microneedles’ aims to bring together recent advancements in the field of microneedles that readers will find informative and useful. The topics could include microneedle fabrication and development approaches, applications of microneedles that add a new dimension to existing core knowledge in the microneedles field, sensing applications and clinical studies that evaluate efficacy or other aspects of microneedle use in humans.

The Guest Editors for this themed collection are: Ester Caffarel-Salvador, Ryan Donnelly, Harvinder Gill and Hyungil Jung

Find out more about the Guest Editors below:

Dr Ester Caffarel-Salvador
Scientific Consultant, USA

‘Microneedles are no longer confined to transdermal drug delivery, they are also being used to deliver drugs to organs such as the eye and the gastrointestinal tract as well as for drug monitoring applications. I am particularly excited to see how microneedles are being employed in novel devices to help overcome the challenges of oral delivery of biologics.’

Dr. Ester Caffarel-Salvador is a multidisciplinary scientist with a background in biotechnology and biochemistry. At MIT, she developed a pill to administer insulin orally, now in clinical trials, which led the MIT Technology Review to recognize her as one of the 35 Innovators Under 35 in 2019.

After taking a mini-MBA at Harvard and working across startups, VCs, consulting, and pharmaceutical companies, Ester is now the Associate Director of Strategic Innovation for Rare Diseases at Chiesi USA. She is also a lecturer at MIT and an advisor to several startups. Ester speaks seven languages and is passionate about advocating on career development for women in science.

Prof. Ryan Donnelly
Queen’s University Belfast, UK

‘Why microneedles? Microneedles are one of the fastest growing areas of innovation in drug and vaccine delivery today. They offer the possibility of needle-free delivery of currently injectable medicines that could help overcome the COVID-induced backlog in healthcare provision globally. In developing countries needle-free vaccine administration would improve access to safe and effective vaccines for millions of people.’

Professor Ryan Donnelly holds the Chair in Pharmaceutical Technology at Queen’s University Belfast and is Director of QUB’s interdisciplinary research programme Materials & Advanced Technologies for Healthcare (MATCH). His personal research is centred on design and physicochemical characterisation of advanced polymeric drug delivery systems for transdermal and intradermal drug delivery, with a strong emphasis on improving patient outcomes. He is currently developing a range of novel microneedle technologies through independent research, but also in collaboration with several major pharma partners. He has obtained substantial UK Research Council, charity and industrial funding and authored over 600 peer-reviewed publications (H-index = 73), including 6 patent applications, 6 textbooks, 23 book chapters and approximately 300 full papers. He has been an invited speaker at numerous national and international conferences. Professor Donnelly is Europe/Africa Editor of Drug Delivery & Translational Research and the Controlled Release Society’s Communications Chair. He has won the Academy of Pharmaceutical Science’s Innovative Science Award (2020), the Controlled Release Society’s Young Investigator Award (2016), BBSRC Innovator of the Year and the American Association of Pharmaceutical Scientists Pharmaceutical Research Meritorious Manuscript Award (2013 and 2022), the GSK Emerging Scientist Award (2012) and the Royal Pharmaceutical Society’s Science Award (2011).

Prof. Harvinder Gill
Texas Tech University, USA

‘The first microneedle paper was published in 1998. I am thrilled at this opportunity to co-edit a joint themed edition for Journal of Materials Chemistry B and Biomaterials Science to showcase the achievements that have been made in the field over the past nearly 25 years. By pairing these two journals for the themed edition, we have a unique opportunity of highlighting both the materials and manufacturing aspects, and the biological applications aspects of microneedles. I look forward to reading the outstanding work in the field from colleagues around the world.’

Dr. Gill is a Professor of Chemical Engineering at Texas Tech University, Lubbock, TX, USA. His research interests are in the fields of immunoengineering and micro-nano medicine. He has expertise in delivery systems such as microneedles, pollen grains, polymeric micro-nano particles, and gold nanoparticles. He has a history of innovativeness, and of providing fresh and unique perspectives to research and medical problems. Dr. Gill is working towards the development of a universal influenza vaccine using nanoparticle systems to enhance vaccine efficacy. He is amongst the pioneers of microneedle technology and has produced seminal work in the field. He was also the first to propose use of pollen grains as “Trojan horses” for oral vaccination and has published original and seminal papers in this field, which has attracted other researchers. He is also the pioneer of the use of microneedles for allergen immunotherapy and his lab is currently developing microneedles for the treatment of airway and peanut allergen immunotherapies. This technology is being commercialized through a startup company called Moonlight Therapeutics, which Dr. Gill has co-founded.

Dr. Gill completed his Bachelor of Engineering in Chemical Engineering with honors and a gold medal from Panjab University, India (1994). After graduation, he worked in the petroleum industry for seven years. Subsequently he obtained his doctoral degree in Bioengineering from Georgia Institute of Technology (2007). Dr. Gill received his postdoctoral training in the field of influenza vaccines at Emory University (2009). Dr. Gill has received numerous awards and honors, including the prestigious NIH Director’s New Innovator Award (DP2 award) and Defense Advanced Research Projects Agency (DARPA) Young Faculty Award for his pollen research, Chancellor’s Council Distinguished Research Award, Barney E. Rushing, Jr. Faculty Distinguished Research Award STEM, Ed and Linda Whitaker Faculty Fellow Award, and Whitacre Engineering Research Award. For his accomplishments and contributions to Biomedical Engineering, he was awarded the Whitacre Endowed Professorship in Science and Engineering at Texas Tech.

Prof. Hyungil Jung
Yonsei University, Korea

‘Microneedles are truly an exciting platform for next generation drug delivery’

Hyungil Jung is a Professor in the Department of Biotechnology at Yonsei University, where he is also the Chair of the Bio & Living Engineering Major in Global Leaders College, as well as Director of the Institute of Bio-Medical Health Care Convergence and the Department Head of Integrative Biotechnology & Translational Medicine. He is also the founder and CSO of JUVIC Inc., a company developing microneedle-based products. He received his B.S. and M.S. from Yonsei University in 1993 and 1995, and his Ph.D. from Cornell University in 2002. He worked at Caltech as a Postdoctoral scholar from 2002 through 2004 and then joined Yonsei University at 2004. His main interests lie in commercialization of microneedles and overcoming the pressing challenges in microneedle development for commercialization. During his spare time, his hobby is indulging in board games, his favorite being Baduk, a widely popular traditional board game in Korea.

Submissions for this themed collection are open until 1 March 2023

The call for papers is open for the following article types:

Communications
Full papers
Reviews
Perspectives

If you would like to submit to this themed collection, you can submit your article directly to the online submission platform for Journal of Materials Chemistry B or Biomaterials Science. Please mention that this submission is a contribution to the Microneedles collection in the “Themed issues” section of the submission form and add a “Note to the Editor” that this is from the Open Call. The Editorial Office reserves the right to check suitability of submissions in relation to the scope of both the journal and the collection, and inclusion of accepted articles in the final themed issue is not guaranteed.

Please note that all submissions will be subject to initial assessment by the journal editors and as such we cannot guarantee peer review or final acceptance of your manuscript. If you have any questions about the collection, email us at materialsb-rsc@rsc.org. We look forward to receiving and featuring your submissions in this exciting collection!

Comments Off on Open Call for Microneedles themed collection: Meet the Guest Editors

Biomaterials Science 10th Anniversary

18 Nov 2022

Join us in celebrating the 10 year anniversary of Biomaterials Science

This year we are proud to celebrate 10 years of Biomaterials Science. Our pilot issue was published in October 2012, and since then we have continued to publish a variety of impactful content from our diverse biomaterials-based community.

We are delighted to announce a number of initiatives to celebrate the journal’s 10^th anniversary. These include a themed collection featuring work from some top researchers in biomaterials; post-publication collections highlighting the top papers from around the world; and a reviewer spotlight recognising some of our outstanding reviewers. You can find out more about our activities below.

The first Biomaterials Science journal cover from October 2012

About the Journal

Biomaterials Science is an international high impact journal exploring the science of biomaterials and their translation towards clinical use. Its scope encompasses new concepts in biomaterials design, studies into the interaction of biomaterials with the body, and the use of materials to answer fundamental biological questions. Since it was first launched in 2012, Biomaterials Science has published over 3000 articles and reviews from research groups in more than 70 countries.

It is the official journal of the European Society for Biomaterials and we publish annual collections highlighting the best work presented at the annual ESB conference.

In line with the Royal Society of Chemistry’s values of inclusion and diversity, Biomaterials Science welcomes work from all areas of biomaterials. High quality is the key determining factor for publishing in Biomaterials Science and we look forward to your continued contributions to the journal.

10th anniversary activities

Biomaterials Science 10th anniversary collection

To introduce the 10^th anniversary collection, current Biomaterials Science Editor-in-Chief Jianjun Cheng and Executive Editor Maria Southall have written an Editorial reflecting on the past 10 years of the journal. They look to the future and highlight various journal initiatives which aim to reinforce the journal’s reputation as an inclusive home for high-quality and impactful research on biomaterials.

Check out the collection featuring high quality research and review articles from some of the top authors in biomaterials. This collection is ongoing and articles will continue to be added as they are published, so do keep checking the collection. We hope you enjoy reading the exciting work featured in the collection for FREE until 31 December 2022.

Post-publication web collections

We have published web collections from four of our key regions featuring some of the most cited, most downloaded and most shared articles published in Biomaterials Science during the first 10 years of the journal.

Check out the collections for FREE until 31 December 2022.

‘Top papers from Europe’

‘Top papers from North America’

Biomaterials Science Emerging Investigator- Vincent Venditto

16 Nov 2022

Dr. Vincent J. Venditto received training in organic synthesis and vaccine development. He obtained a BS in chemistry from Gettysburg College and then worked for two years at the NCI, NIH as a cancer research trainee before attending graduate school. He obtained a PhD in chemistry from Texas A&M University and worked on vaccine development as an NIH postdoctoral fellow at University of California, San Francisco.

Students and fellows in his lab come from diverse backgrounds with interests in chemistry, biology, drug delivery and experimental therapeutics, but a common goal of exploring novel methods to modulate the immune system. Students and fellows in his lab are encouraged to utilize their skills to advance projects while learning new skills to better appreciate the various aspects of designing novel immunotherapies.

You can find out more about Vincent and his research on his webpage

Follow Vincent on Twitter @vjvenditto

Read Vincent’s Emerging Investigator article, ‘In vivo assessment of triazine lipid nanoparticles as transfection agents for plasmid DNA’, DOI: 10.1039/D2BM01289H

Check out our interview with Vincent below:

1. How do you feel about Biomaterials Science as a place to publish research on this topic?

Biomaterials science is a great journal to publish novel lipids for gene delivery. The interdisciplinary nature of our work is highlighted by the broad readership of Biomaterials Science.

2. What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?

The lipids presented in the manuscript demonstrate in vitro and in vivo transfection efficiency, and importantly demonstrates a platform for continued iterative development of novel lipids for improved nucleic acid delivery.

3. In your opinion, what are the most important questions to be asked/answered in this field of research?

How do we improve upon the success achieved with the COVID-19 vaccines?

4. Can you share one piece of career-related advice or wisdom with other early career scientists?

Do what excites you.

Comments Off on Biomaterials Science Emerging Investigator- Vincent Venditto

Biomaterials Science 10th Anniversary Reviewer Spotlight- Honggang Cui

15 Nov 2022

Biomaterials Science is delighted to recognise our outstanding reviewers for their support and significant contributions to the journal. As part of the 10th Anniversary celebrations, we are highlighting some of our most loyal reviewers in a ‘Reviewer Spotlight’ series. We are grateful to all our reviewers and appreciate the dedication and support they give to the journal.

Honggang Cui is a Biomaterials Science reviewer and has received an outstanding reviewer award for his contributions to the journal in 2020. Find out more about Honggang below and read his interview with advice for reviewers for the journal.

Honggang Cui is an associate professor of chemical and biomolecular engineering at The John Hopkins University with a joint appointment in the Department of Materials Science and Engineering. Dr. Cui works on the development of supramolecular biomaterials and drug-based assemblies, with the goal of improving the current treatment and prevention of some important human diseases.

1. What do you like most about being a reviewer for Biomaterials Science?

The opportunity to learn something exciting and new. I also enjoy having the opportunity to help the authors improve the quality of their manuscript.

2. What would you recommend to new reviewers to ensure their report is helpful?

A manuscript cannot solve all the problems in the field. So long as a manuscript can teach us something new and important, it is a good manuscript worthy of sharing with the community. Questions raised should be centered on the key points that the authors tried to convey in their manuscript. Even if you recommend rejection, please explain your rationale and provide constructive suggestions as to how the manuscript can be further improved.

You can find out more about Honggang and his research on his webpage

Comments Off on Biomaterials Science 10th Anniversary Reviewer Spotlight- Honggang Cui

Biomaterials Science 10th Anniversary Reviewer Spotlight- Yongzhuo Huang

15 Nov 2022

Yongzhuo Huang is a Biomaterials Science reviewer and has received an outstanding reviewer award for his contributions to the journal in 2019. Find out more about Yongzhuo below and read his interview about his experiences of being a reviewer.

Yongzhuo Huang is currently a Professor of Pharmaceutics at the Shanghai Institute for Materia Medica at the Chinese Academy of Sciences. He received his Ph.D. from Zhejiang University and then conducted postdoctoral training at the University of Michigan College of Pharmacy. He focuses on application of drug delivery technology to explore the new therapeutic mechanisms and strategies in cancer and inflammation diseases. He is interested in targeted drug delivery, transdermal delivery, and protein delivery.

He has published over 150 articles, and supervised/co-supervised 50 graduates, 20 PhD students, and 8 postdoctoral researchers.

He is an editor of International Journal of Pharmaceutics, and serves in the advisory or editorial boards of Nano Letters, Journal Controlled Release, Acta Pharmaceutica Sinica B, Cancer Biology & Medicine and Medicine in Drug Discovery. He has also served as a Guest Editor for various theme issues, including the issue of “Biomimetic Therapeutics” in Biomaterials Science (2019). He is an active reviewer for over 120 scientific journals.

1. What encouraged you to become a reviewer for Biomaterials Science?

Biomaterials Science is a well-respected journal covering multidisciplinary areas. I like to keep myself posted on the up-to-date cutting-edge research to be published in the journal. Moreover, I have authored a number of articles in BM, and thanks to the excellent reviewers, their valuable comments did help me a lot improve the quality of the articles. As a way to give back, I am more than happy to serve as a reviewer for BM.

2. What would you recommend to new reviewers to ensure their report is helpful?

When I review a manuscript, I often ask myself what I will do if I am going to conduct a similar study. I will compare the plan conceived in my mind with the work in the manuscript and try to find out the pros and cons. Originality and solidness is two essential criteria to evaluate a manuscript. If a reviewer can provide a detailed analysis of originality of the work and solidness of the experiments will be helpful for the authors to improve their work and for the editors to make a decision. Please treat a manuscript in a way what you want yours to be treated.

3. Has being a reviewer affected how you approach the preparation of your recent manuscripts?

Yes. I do learn a lot from being a reviewer. When a manuscript leaves me a deep impression, I would try to find out which elements stick in my mind. From a critical reading of a manuscript, I can appreciate the well-organized structure, clear presentation, and the way to prepare the beautiful schemes and figures. Such experience will affect my manuscript-writing, in various aspects.

You can find out more about Yongzhuo and his research on his webpage.

Comments Off on Biomaterials Science 10th Anniversary Reviewer Spotlight- Yongzhuo Huang

Biomaterials Science Blog

Author Archive

Congratulations to the winners of the Bioceramics34 Young Scientist awards

Open Call for Papers: Novel Biomedical Polymer Materials

Biomaterials Science- Lunar New Year 2023

Biomaterials Science Overview of 2022

Biomaterials Science Emerging investigator- Christopher Rodell

Open Call for Microneedles themed collection: Meet the Guest Editors

Biomaterials Science 10th Anniversary

Biomaterials Science Emerging Investigator- Vincent Venditto

Biomaterials Science 10th Anniversary Reviewer Spotlight- Honggang Cui

Biomaterials Science 10th Anniversary Reviewer Spotlight- Yongzhuo Huang

Links

Categories

Archives

Meta